A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia

The Journal of Urology
R C BruskewitzJ E Oesterling

Abstract

We assess the 1-year efficacy and safety of transurethral needle ablation of the prostate compared to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH). A prospective, randomized clinical trial of 121 men 50 years old or older with symptomatic BPH was performed at 7 medical centers across the United States. Of the men 65 (54%) were treated with transurethral needle ablation of the prostate and 56 (46%) underwent transurethral resection of the prostate. Mean and percentage changes from baseline and between cohorts for American Urological Association (AUA) symptom score, AUA bother score, quality of life score, peak urinary flow rate and post-void residual urine volume were measured at 1, 3, 6 and 12 months following treatment. Length of procedure, hospitalization, type of anesthesia, post-procedure catheterization, side effects and sexual function were compared. Transurethral needle ablation and resection resulted in a statistically significant improvement in AUA symptom, bother and quality of life scores, peak urinary flow rate and post-void residual. At 1-year followup, needle ablation and resection were equally effective in enhancing quality of life. Needle ablation ha...Continue Reading

References

Oct 22, 1992·The New England Journal of Medicine·G J GormleyJ S Tenover
Jan 1, 1990·The Prostate. Supplement·R C Bruskewitz, M M Christensen
Nov 1, 1990·British Journal of Urology·D R JonesW B Peeling
Dec 1, 1990·British Journal of Urology·D R Lyth, C M Booth
Jan 1, 1990·Urology·K K Nielsen, J Nordling
Mar 1, 1989·The Journal of Urology·P H GraversenR C Bruskewitz
Dec 1, 1994·The Journal of Urology·S MadersbacherM Marberger
Feb 1, 1997·The Journal of Urology·J J de la RosetteF M Debruyne
Aug 1, 1997·Urology·M J Naslund

❮ Previous
Next ❯

Citations

Apr 12, 2002·Journal of Magnetic Resonance Imaging : JMRI·John D HazleR Jason Stafford
Feb 13, 2008·Der Urologe. Ausg. A·R Muschter, O Reich
Sep 17, 2009·Der Urologe. Ausg. A·R BergesUNKNOWN Society of German Urologists
Jul 22, 2006·World Journal of Urology·Sas Barmoshe, Alexandre R Zlotta
Mar 3, 2007·International Urology and Nephrology·Emerson Luís Zani, Nelson Rodrigues Netto
Jun 27, 2002·Current Urology Reports·P K HegartyJ M Fitzpatrick
May 21, 2003·Current Urology Reports·Harrie P Beerlage
May 8, 2000·The Journal of Urology·R S MalekD M Barrett
Dec 26, 2001·Urology·M L Blute, T Larson
Mar 27, 1999·Urology·A ZiadaE D Crawford
Apr 1, 1999·European Journal of Ultrasound : Official Journal of the European Federation of Societies for Ultrasound in Medicine and Biology·N J Hegarty, J M Fitzpatrick
Feb 19, 1999·Journal of the American College of Surgeons·J P Richie
Jun 19, 2009·International Journal of Impotence Research·T A Skolarus, J T Wei
Mar 22, 2001·International Journal of Urology : Official Journal of the Japanese Urological Association·M MuraiE Okajima
Jan 26, 2000·Journal of Endourology·M A HolmesR M Chambers
Nov 3, 2001·BMJ : British Medical Journal·M J Barry, C G Roehrborn
Jun 27, 2002·Current Urology Reports·J J de la RosetteM P Laguna
Apr 25, 2003·Lancet·A Thorpe, D Neal
Apr 1, 2015·Postgraduate Medicine·David MobleyNeil Baum
Feb 3, 2007·Current Medical Research and Opinion·Jed Kaminetsky
Jan 1, 2014·Sexual Medicine Reviews·Edgardo F Becher, Kevin T McVary
Aug 28, 2012·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·N B DelongchampsM Peyromaure
Jul 17, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Giancarlo MarraPaolo Gontero
Sep 14, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·E XylinasA Descazeaud
Sep 18, 2007·The Journal of Urology·Dean E LeocádioBarry S Stein
Apr 29, 2005·International Journal of Clinical Practice·D J Martin, J P Mulhall
Jun 26, 2003·International Journal of Urology : Official Journal of the Japanese Urological Association·Kiyohide FujimotoYoshiki Hayashi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.